MX339605B - Proceso mejorado para produccion de la hormona de crecimiento humano recombinante. - Google Patents

Proceso mejorado para produccion de la hormona de crecimiento humano recombinante.

Info

Publication number
MX339605B
MX339605B MX2013003049A MX2013003049A MX339605B MX 339605 B MX339605 B MX 339605B MX 2013003049 A MX2013003049 A MX 2013003049A MX 2013003049 A MX2013003049 A MX 2013003049A MX 339605 B MX339605 B MX 339605B
Authority
MX
Mexico
Prior art keywords
production
growth hormone
improved process
human growth
recombinant human
Prior art date
Application number
MX2013003049A
Other languages
English (en)
Other versions
MX2013003049A (es
Inventor
Dov Kanner
Eli Schmell
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2013003049A publication Critical patent/MX2013003049A/es
Publication of MX339605B publication Critical patent/MX339605B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un proceso mejorado para la producción de la hormona del crecimiento humano.
MX2013003049A 2010-09-21 2011-09-20 Proceso mejorado para produccion de la hormona de crecimiento humano recombinante. MX339605B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10177997 2010-09-21
PCT/IB2011/002348 WO2012038822A1 (en) 2010-09-21 2011-09-20 Improved process for production of recombinant human growth hormone

Publications (2)

Publication Number Publication Date
MX2013003049A MX2013003049A (es) 2013-06-24
MX339605B true MX339605B (es) 2016-06-02

Family

ID=43989870

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013003049A MX339605B (es) 2010-09-21 2011-09-20 Proceso mejorado para produccion de la hormona de crecimiento humano recombinante.

Country Status (16)

Country Link
US (2) US8765411B2 (es)
EP (1) EP2619222B1 (es)
JP (1) JP5924343B2 (es)
KR (1) KR101935334B1 (es)
CN (1) CN103119056B (es)
AR (1) AR083074A1 (es)
AU (1) AU2011306653B2 (es)
BR (1) BR112013008103B1 (es)
CA (1) CA2811709C (es)
ES (1) ES2566781T3 (es)
HK (1) HK1187058A1 (es)
IL (1) IL225008A (es)
MX (1) MX339605B (es)
NZ (1) NZ607633A (es)
RU (1) RU2592671C2 (es)
WO (1) WO2012038822A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742004A (en) * 1984-08-27 1988-05-03 Bio-Technology General Corp. Method for producing enzymatically active eucaryotic sod in bacteria
NZ246556A (en) * 1991-12-20 1996-03-26 Novo Nordisk As Pharmaceutical composition of a growth hormone and histidine
JP2971290B2 (ja) * 1993-04-27 1999-11-02 オリエンタル酵母工業株式会社 プラスミド及びそれで形質転換されたエシェリチア・コリ
ATE184798T1 (de) * 1994-06-17 1999-10-15 Applied Research Systems Hgh enthaltende pharmazeutische zubereitungen
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
US6482632B1 (en) * 1999-03-29 2002-11-19 Council Of Scientic And Industrial Research Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof
SE9904502D0 (sv) * 1999-12-09 1999-12-09 Pharmacia & Upjohn Ab Production of peptides
US7541171B2 (en) * 2003-08-11 2009-06-02 Codexis, Inc. Halohydrin dehalogenases and related polynucleotides
CN100434522C (zh) * 2003-11-21 2008-11-19 上海新生源医药研究有限公司 重组人生长激素的生产方法
JP4972412B2 (ja) * 2004-02-04 2012-07-11 メルク・シャープ・エンド・ドーム・コーポレイション E.コリ発酵によるプラスミドdnaの大規模生産のための方法
CA2589716A1 (en) 2004-12-21 2006-06-29 Usv Limited Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms
US20090035807A1 (en) * 2007-07-31 2009-02-05 Wyeth Analysis of polypeptide production
CN101250525A (zh) * 2008-04-09 2008-08-27 西安融智生物技术有限公司 一种表达重组人生长激素的方法及其专用表达盒

Also Published As

Publication number Publication date
AU2011306653A1 (en) 2013-03-21
RU2592671C2 (ru) 2016-07-27
ES2566781T3 (es) 2016-04-15
EP2619222A1 (en) 2013-07-31
JP5924343B2 (ja) 2016-05-25
MX2013003049A (es) 2013-06-24
JP2013541946A (ja) 2013-11-21
WO2012038822A1 (en) 2012-03-29
KR101935334B1 (ko) 2019-01-04
BR112013008103A2 (pt) 2016-08-09
RU2013111944A (ru) 2014-10-27
HK1187058A1 (zh) 2014-03-28
EP2619222B1 (en) 2016-01-06
US8765411B2 (en) 2014-07-01
CN103119056B (zh) 2015-11-25
IL225008A (en) 2017-01-31
CA2811709A1 (en) 2012-03-29
KR20130138755A (ko) 2013-12-19
NZ607633A (en) 2014-07-25
US9102970B2 (en) 2015-08-11
AR083074A1 (es) 2013-01-30
US20140255992A1 (en) 2014-09-11
CA2811709C (en) 2019-08-13
AU2011306653B2 (en) 2014-06-05
CN103119056A (zh) 2013-05-22
US20130171693A1 (en) 2013-07-04
BR112013008103B1 (pt) 2021-01-26

Similar Documents

Publication Publication Date Title
MX2013015311A (es) Polipeptidos de enlace de pcsk9 y metodos de uso.
MX355543B (es) Macrociclos peptidomiméticos.
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
MY170713A (en) Treatment protocol of diabetes type 2
IN2014DN11201A (es)
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
TN2013000378A1 (en) Anti - sclerostin antibody crystals and formulations thereof
JO3755B1 (ar) تركيبات تستوستيرون
MX2013000958A (es) Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
IN2012MU03723A (es)
MX2013011853A (es) Polipeptidos antibacterianos quimericos.
IN2013MU00848A (es)
IN2014DN09450A (es)
IN2013MU00646A (es)
MX2016004325A (es) Nuevo derivado de un analogo de insulina.
IN2014DN00254A (es)
IN2013MN00733A (es)
MX2011012623A (es) Construcciones de casb7439.
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
IN2015DN03132A (es)
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
GEP201706636B (en) Galactagogue compositions based on phosphatidylserine
IN2014DN10209A (es)
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia

Legal Events

Date Code Title Description
FG Grant or registration